Zhejiang International Group Company Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang International Group Company Limited with three other
companies in this sector in China:
Yunnan Baiyao Group Co., Ltd.
sales of 24.31 billion Chinese Renmimbi [US$3.55 billion]
of which 59%
was Comodities Trading),
Realcan Pharmaceutical Co Ltd
(23.29 billion Chinese Renmimbi [US$3.41 billion]
of which 100%
was Medical Devices Sales), and
Cachet Pharmaceutical Company., Limited
(14.24 billion Chinese Renmimbi [US$2.08 billion]
of which 98%
was Medical Wholesale).
Zhejiang International Group Company Limited reported sales of 18.91 billion Chinese Renmimbi (US$2.76 billion)
December of 2017.
increase of 9.6%
versus 2016, when the company's sales were 17.26 billion Chinese Renmimbi.
Sales at Zhejiang International Group Company Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 79%).
Sales of Other Business saw an increase
15.3% in 2017, from
37.75 million Chinese Renmimbi to 43.51 million Chinese Renmimbi.
Not all segments of Zhejiang International Group Company Limited experienced an increase in sales in 2017:
sales of Leasing Business fell 36.7% to 3.96 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Zhejiang International Group Company Limited also experienced decreases in sales in
Warehousing and Transportation (down 2.3% to 24.64 million Chinese Renmimbi)